FDA Approves Eticovo (etanercept-ykro), a Biosimilar to Enbrel (etanercept)

April 26, 2019 The FDA has approved Eticovo (etanercept-ykro), a biosimilar to U.S.-licensed Enbrel (etanercept). A biosimilar product is a biological product that is approved based on a showing that it is highly similar to an already-FDA approved...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news